Dr Reddy’s Laboratories on Thursday reported an 85.62% fall in net profit for the quarter ended March to ₹74.60 crore from ₹518.80 crore a year ago. The company attributed the decline to the write-down of outstanding receivables from Venezuela and lower sales. For the entire fiscal, net profit fell 10% to ₹2,001.3 crore, while sales grew 4% to ₹15,470.8 crore.